Download PDF
Am J Perinatol 1997; 14(1): 5-6
DOI: 10.1055/s-2007-994087
ORIGINAL ARTICLE

© 1997 by Thieme Medical Publishers, Inc.

Is Maternal Thyrotropin Releasing Hormone Administration Safe in the Pregnant Woman with Preeclampsia?

Ann S.A. Tan, Chaur-Dong Hsu, Sara Marder, Joshua A. Copel
  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut
Further Information

Publication History

Publication Date:
04 March 2008 (online)

    Permissions and Reprints

ABSTRACT

Maternal intravenous administration of thyrotropin releasing hormone (TRH) is associated with rapid elevations of blood pressure, potentially causative of cerebrovascular accidents. We report a case in which peak blood pressure of 220/120 mm Hg was attained from a baseline of 132/80 mm Hg following TRH administration in a preeclamptic patient.

Keywords

Preeclampsia - thyrotropin releasing hormone (TRH) - blood pressure

      >